Atlas Trials

Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19

Clinical trial NCT04646655 · COMPLETED

Trial details

NCT number
NCT04646655
Sponsor
ASST Fatebenefratelli Sacco
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19Thrombosis
Start date
2020-07-27
Primary completion
2022-10-16
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.